Suchergebnisse - "Lippi, Giuseppe"

PubPharm (29)

1

SARS-CoV-2 antibodies in inflammatory neurological conditions : a multicentre retrospective comparative study

enthalten in: Immunologic research | 2023

von Zivelonghi, C. | Dinoto, A. | Irani, S. | +17

2

Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Lippi, G. | Henry, B. | Plebani, M.

3

Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine : a proof-of-concept study

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Salvagno, G. | Pighi, L. | Henry, B. | +3

4

Cellular immunity against SARS-CoV-2 depends on the serological status

enthalten in: The Journal of infection | 2023

von Pighi, L. | Henry, B. | De Nitto, S. | +2

CommentIn: J Infect. 2023 Aug;87(2):e31-e32. - PMID 37211218

5

Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Salvagno, G. | Pighi, L. | Henry, B. | +7

6

Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation

enthalten in: International journal of molecular sciences | 2023

von Lucca, F. | Bezzerri, V. | Danese, E. | +10

7

The Comparability of Anti-SARS-CoV-2 IgG Levels Measured with Different Immunoassays Varies over Time after Primary BNT162b2 Vaccination and Homologous Booster Immunization

enthalten in: Microbiology spectrum | 2022

von Salvagno, G. | Lippi, G.

CommentOn: Microbiol Spectr. 2022 Feb 23;10(1):e0140221. - PMID 35196824

8

Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination : A systematic review

enthalten in: Journal of medical virology | 2022

von Notarte, K. | Guerrero-Arguero, I. | Velasco, J. | +10

9

Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: Clin Chem Lab Med. 2022 Apr 27;60(7):1110-1115. - PMID 35473824

10

Serum C reactive protein predicts humoral response after BNT162b2 booster administration

enthalten in: The Journal of infection | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +2